GlassScriptPhysician profile
Felice Moody
NPI 1710934633
$1,673.16
in general payments reported to CMS, 2019-2025
14 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $29.10 · 2021: $32.74 · 2022: $80.13 · 2024: $175 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $985.15 | 2019 | |
| Smith+Nephew, INC. | $137.90 | 2022-2025 | Collagenase Santyl, Grafix Pl, Pico |
| Hartmann USA, INC. | $115.85 | 2025 | Zetuvit Plus 10x10 P10 |
| Avita Medical Americas, LLC | $69.92 | 2025 | Permeaderm, Cohealyx, Recell |
| Aroa Biosurgery Incorporated | $68.47 | 2025 | |
| Mentor Worldwide LLC | $53.72 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $41.06 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Motiva USA, LLC | $38.22 | 2025 | |
| Abbvie INC. | $38.10 | 2024 | |
| Kci USA, INC. | $33.97 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $29.10 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $28.66 | 2025 | |
| Organogenesis INC. | $18.55 | 2024 | Puraply Am |
| Sanara Medtech INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felice Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.